CAM
HALO icon

Claret Asset Management’s Halozyme HALO Stock Holding History

Claret Asset Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$229K Sell
2,923
-1,393
-32% -$95K 0.02% 280
2026
Q1 		$279K Buy
4,316
+1
+0% +$70 0.03% 208
2025
Q4 		$290K Sell
4,315
-11
-0.3% -$740 0.03% 191
2025
Q3 		$317K Buy
+4,326
New +$287K 0.04% 147

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Claret Asset Management's HALO Position: Q2 2026 in Review

Claret Asset Management reduced its Halozyme (HALO) stake by 32% in Q2 2026, selling an estimated $95K and leaving 2,923 shares worth $229K. The position accounts for 0.02% of the portfolio, ranked #280.

Claret Asset Management first reported a position in HALO in Q3 2025 and has held it in 4 quarters since. The position peaked at $317K in Q3 2025. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Claret Asset Management held 2,923 shares of Halozyme worth $229K as of Q2 2026.
  • Claret Asset Management sold 1,393 Halozyme shares in Q2 2026, an estimated $95K.
  • Halozyme made up 0.02% of Claret Asset Management's portfolio in Q2 2026, its #280 holding.
  • Claret Asset Management first reported a position in Halozyme in Q3 2025 and has held it in 4 quarters since.
  • Claret Asset Management's Halozyme position peaked at $317K in Q3 2025.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Claret Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.